Prime Capital Investment Advisors LLC Sells 4,846 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Prime Capital Investment Advisors LLC lowered its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 3.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 129,444 shares of the company’s stock after selling 4,846 shares during the period. Prime Capital Investment Advisors LLC owned about 1.75% of VanEck Pharmaceutical ETF worth $12,301,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in PPH. Optimum Investment Advisors bought a new position in shares of VanEck Pharmaceutical ETF during the 2nd quarter valued at $27,000. GPS Wealth Strategies Group LLC purchased a new stake in VanEck Pharmaceutical ETF during the 2nd quarter valued at $42,000. CWM LLC purchased a new stake in VanEck Pharmaceutical ETF during the 2nd quarter valued at $55,000. International Assets Investment Management LLC purchased a new stake in VanEck Pharmaceutical ETF during the 2nd quarter valued at $86,000. Finally, Comerica Bank boosted its position in VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock valued at $121,000 after buying an additional 378 shares during the period.

VanEck Pharmaceutical ETF Price Performance

PPH traded down $0.44 during trading on Tuesday, hitting $90.25. 26,492 shares of the stock traded hands, compared to its average volume of 147,333. The firm has a market capitalization of $666.95 million, a P/E ratio of 21.04 and a beta of 0.72. The firm has a 50-day moving average of $94.44 and a 200 day moving average of $93.03. VanEck Pharmaceutical ETF has a 12-month low of $75.50 and a 12-month high of $99.51.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.